Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vieworks CoXKRX:100120 -2.06%93 Pretax Margin % is 27.44% as of Jun. 2026, which is 51% above its 10-year median of 18.15. GuruFocus rates XKRX:100120 with a GF Score™ of 93/100 and a GF Value™ of ₩28,030.42 (Fairly Valued). The stock has 5 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Vieworks Co ranks better than 83.46% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Vieworks Co's Pre-Tax Income for the
three
months ended in Jun. 2026 was ₩17,529 Mil. Vieworks Co's Revenue for the
three
months ended in Jun. 2026 was ₩63,877 Mil. Therefore, Vieworks Co's pretax margin for the quarter that ended in Jun. 2026 was 27.44%.
The historical rank and industry rank for Vieworks Co's Pretax Margin % or its related term are showing as below:
XKRX:100120'
s Pretax Margin % Range Over the Past 10 Years
Min: 7.58 Med: 18.15 Max: 28.45
Current: 19.76
XKRX:100120's Pretax Margin % is ranked better than 83.46% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 3.01
vs XKRX:100120: 19.76
Vieworks Co (XKRX:100120) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Vieworks Co Pretax Margin % Related Terms
Vieworks Co Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Vieworks Co's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:100120 vs ABT, SYK, MDT: Pretax Margin % Comparison
For the Medical Devices subindustry, Vieworks Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vieworks Co Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vieworks Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Vieworks Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vieworks Co (XKRX:100120) has a Pretax Margin % of 27.44% as of Jun. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Vieworks Co and its competitors. This is 51% above median its historical median of 18.15. Over the past decade, Vieworks Co's Pretax Margin % has ranged from 7.58 to 28.45. According to the industry distribution chart, Vieworks Co ranks #135 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 16.5%.
Is Vieworks Co's Pretax Margin % too high?
Vieworks Co's current Pretax Margin % of 27.44% is 51% above median its 10-year median of 18.15. Over the past 10 years, this metric has ranged from a low of 7.58 to a high of 28.45. The Medical Devices & Instruments industry median Pretax Margin % is 3.01. Vieworks Co's value of 27.44% is 811.6% above this industry median. Based on the distribution chart, Vieworks Co ranks #135 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Vieworks Co has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Vieworks Co's Pretax Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Vieworks Co ranks #135 out of 816 companies for Pretax Margin %. This places Vieworks Co in the top 17% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 3.01. Vieworks Co's value of 27.44% is 811.6% above this benchmark. Historically, Vieworks Co's own Pretax Margin % has ranged from 7.58 to 28.45 over the past decade. While the company's 10-year median is 18.15 vs. the industry median of 3.01, Vieworks Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 3.01, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vieworks Co's current Pretax Margin % of 27.44% is 811.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Vieworks Co and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 3.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vieworks Co's current Pretax Margin % is 27.44%, which is 51% above median its own 10-year median of 18.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vieworks Co stock overvalued right now?
Based on GuruFocus' analysis, Vieworks Co (XKRX:100120) is currently considered Fairly Valued. The stock's GF Value™ is ₩28,030.42, compared to a current price of ₩26,200.00 — trading 6.5% below its estimated fair value. The current Pretax Margin % is 27.44%, which is 51% above median its 10-year median of 18.15 and 811.6% above the Medical Devices & Instruments industry median of 3.01. Vieworks Co's overall GF Score™ is 93/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Vieworks Co (XKRX:100120), the current Pretax Margin % is 27.44% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vieworks Co (XKRX:100120) Overvalued in 2026?
Based on GuruFocus' analysis, Vieworks Co stock appears to be undervalued.
The current stock price of ₩26,200.00 is trading 6.5% below its estimated GF Value™ of ₩28,030.42.
GuruFocus considers Vieworks Co to be Fairly Valued.
Key valuation signals for XKRX:100120:
Pretax Margin %: 27.44% (51% above median its 10-year median of 18.15)
GF Value™: ₩28,030.42 vs. price of ₩26,200.00 (6.5% below fair value)
Industry Position: 811.6% above the Medical Devices & Instruments median (#135 of 816)
No single metric tells the full story. See the XKRX:100120 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vieworks Co Ltd designs, develops, manufactures and provides camera systems and digital imaging systems for digital radiography, digital fluoroscopy and angiography systems and also medical imaging processing, signal processing for an image sensor, high precision optics and optomechanical design. Its products include Vivix-S series and D series, Slimpac 2 series, Camera, Lenses etc.
93GF Score
Get the complete analysis for XKRX:100120
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:100120 has been successfully added to your 
